Stone Ridge Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,130
Closed -$733K 1023
2019
Q3
$733K Hold
9,130
0.04% 526
2019
Q2
$731K Hold
9,130
0.04% 545
2019
Q1
$725K Sell
9,130
-9,107
-50% -$681K 0.04% 555
2018
Q4
$1.33M Buy
18,237
+1,142
+7% +$80.6K 0.08% 299
2018
Q3
$1.16M Buy
17,095
+3,142
+23% +$200K 0.06% 401
2018
Q2
$808K Buy
13,953
+3,080
+28% +$174K 0.05% 535
2018
Q1
$565K Sell
10,873
-31,859
-75% -$1.72M 0.03% 717
2017
Q4
$2.29M Buy
+42,732
New +$2.37M 0.14% 142

Other funds holding MRK

Stone Ridge Asset Management's MRK Position: Q4 2019 in Review

Stone Ridge Asset Management sold out of Merck (MRK) in Q4 2019, closing a stake of 9,130 shares — an estimated $733K sold.

Stone Ridge Asset Management first reported a position in MRK in Q4 2017 and held it in 8 quarters. The position peaked at $2.29M in Q4 2017. 2,537 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • Stone Ridge Asset Management reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 9,130 Merck shares in Q4 2019, an estimated $733K.
  • Stone Ridge Asset Management first reported a position in Merck in Q4 2017 and held it in 8 quarters.
  • Stone Ridge Asset Management's Merck position peaked at $2.29M in Q4 2017.
  • 2,537 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Stone Ridge Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.